MXPA03009984A - PREPARACION PARA LA REMOCIoN DE MATERIAL QUERATINOSO ANORMAL. - Google Patents

PREPARACION PARA LA REMOCIoN DE MATERIAL QUERATINOSO ANORMAL.

Info

Publication number
MXPA03009984A
MXPA03009984A MXPA03009984A MXPA03009984A MXPA03009984A MX PA03009984 A MXPA03009984 A MX PA03009984A MX PA03009984 A MXPA03009984 A MX PA03009984A MX PA03009984 A MXPA03009984 A MX PA03009984A MX PA03009984 A MXPA03009984 A MX PA03009984A
Authority
MX
Mexico
Prior art keywords
removal
preparation
keratin material
abnormal keratin
abnormal
Prior art date
Application number
MXPA03009984A
Other languages
English (en)
Spanish (es)
Inventor
Horst Ulbricht
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MXPA03009984A publication Critical patent/MXPA03009984A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03009984A 2001-05-30 2002-05-17 PREPARACION PARA LA REMOCIoN DE MATERIAL QUERATINOSO ANORMAL. MXPA03009984A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126501A DE10126501A1 (de) 2001-05-30 2001-05-30 Zubereitung zur Entfernung von abnormen Keratinmaterial
PCT/EP2002/005469 WO2002098380A1 (de) 2001-05-30 2002-05-17 Zubereitung zur entfernung von abnormen keratinmaterial

Publications (1)

Publication Number Publication Date
MXPA03009984A true MXPA03009984A (es) 2004-02-12

Family

ID=7686754

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009984A MXPA03009984A (es) 2001-05-30 2002-05-17 PREPARACION PARA LA REMOCIoN DE MATERIAL QUERATINOSO ANORMAL.

Country Status (11)

Country Link
US (2) US20020197291A1 (enExample)
EP (1) EP1395231B1 (enExample)
JP (1) JP4359140B2 (enExample)
AT (1) ATE296607T1 (enExample)
CA (1) CA2448829C (enExample)
DE (2) DE10126501A1 (enExample)
DK (1) DK1395231T3 (enExample)
ES (1) ES2242027T3 (enExample)
MX (1) MXPA03009984A (enExample)
PT (1) PT1395231E (enExample)
WO (1) WO2002098380A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50012415D1 (de) * 2000-01-03 2006-05-11 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
ES2337359T3 (es) * 2003-04-24 2010-04-23 L'oreal Procedimiento de exfoliacion que utiliza urea.
JP2007503402A (ja) * 2003-08-25 2007-02-22 バイオイコール ア−ゲー 局所適用性産物およびその使用
DE102006049586A1 (de) * 2006-10-22 2008-04-24 Rudy Susilo Nagellackenferner für kosmetische und medizinische Anwendungen
US8293174B2 (en) * 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
US20090191138A1 (en) * 2008-01-30 2009-07-30 Mediquest Therapeutics, Inc. Novel topical formulations for improving the appearance of nails
NL1035426C2 (nl) * 2008-05-15 2009-11-17 Atp Marketing & Promotion Ag Farmaceutische samenstellingen voor de behandeling van wratten.
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
KR101055963B1 (ko) * 2008-12-01 2011-08-11 (주)더페이스샵 각질 박리 촉진용 화장료 조성물
WO2012110430A1 (en) * 2011-02-10 2012-08-23 Moberg Derma Ab Novel composition for topical use on a nail
US8673279B2 (en) 2011-08-31 2014-03-18 Avon Products, Inc. Cosmetic liquid extractor comprising nonionic polymers
US9770609B2 (en) 2015-04-01 2017-09-26 Neat Feat Products Limited Urea based skin treatment
CN116211725A (zh) * 2022-12-13 2023-06-06 无锡知妍生物科技有限公司 一种洗去类高浓度尿素去角质凝胶及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402935A (en) * 1981-04-16 1983-09-06 Del Laboratories, Inc. Moisturizing nail polish composition
DE3520098A1 (de) * 1985-06-05 1986-12-11 Bayer Ag, 5090 Leverkusen Azolderivate enthaltende formulierungen sowie ihre verwendung zur atraumatischen nagelentfernung
DE3687458T2 (de) 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5098421A (en) * 1989-10-16 1992-03-24 Zook Gerald P Viscoelastic gel foot padding and medicating device
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
DE4337945A1 (de) 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5639740A (en) * 1995-03-10 1997-06-17 Crandall; Wilson Trafton Topical moisturizing composition and method
US5834513A (en) * 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5993790A (en) * 1997-08-04 1999-11-30 Pedinol Pharmacal Inc. Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections
US5919470A (en) * 1998-04-02 1999-07-06 Bradley Pharmaceuticals, Inc. Dermatological composition
DE50012415D1 (de) * 2000-01-03 2006-05-11 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6753071B1 (en) * 2001-09-27 2004-06-22 Advanced Cardiovascular Systems, Inc. Rate-reducing membrane for release of an agent
US6495602B1 (en) * 2001-12-13 2002-12-17 Bradley Pharmaceuticals, Inc. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
US6673842B2 (en) * 2002-03-20 2004-01-06 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis
US6743417B2 (en) * 2002-04-22 2004-06-01 Bradley Pharmaceuticals, Inc. Method of treating onychomycosis with urea and an antioxidant
US6573301B1 (en) * 2002-04-23 2003-06-03 Bradley Pharmaceuticals, Inc. Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
DK1395231T3 (da) 2005-09-12
PT1395231E (pt) 2005-08-31
JP2004532268A (ja) 2004-10-21
EP1395231B1 (de) 2005-06-01
US20040146555A1 (en) 2004-07-29
WO2002098380A1 (de) 2002-12-12
CA2448829A1 (en) 2002-12-12
EP1395231A1 (de) 2004-03-10
US20020197291A1 (en) 2002-12-26
ATE296607T1 (de) 2005-06-15
DE10126501A1 (de) 2002-12-12
CA2448829C (en) 2010-04-20
US7476396B2 (en) 2009-01-13
JP4359140B2 (ja) 2009-11-04
DE50203283D1 (de) 2005-07-07
ES2242027T3 (es) 2005-11-01

Similar Documents

Publication Publication Date Title
HUP0101176A3 (en) Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases, process for their preparation and pharmaceutical compositions containing them
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2002041837A3 (en) Treatment of mucositis
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
MY129406A (en) Taste masked liquid pharmaceutical compositions
WO2003053383A3 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
ATE296607T1 (de) Zubereitung zur entfernung von abnormen keratinmaterial
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
WO2004069138A3 (en) Pharmaceutical formulation
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
PL346764A1 (en) New oral formulation for 5-ht4
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
WO2002060394A3 (de) Revitalisierender wirkkomplex für die haut
AU1701402A (en) Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0302291A3 (en) Sulfonamide derivatives, process for their preparation and their use for preparation of pharmaceutical compositions
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
HUP0303804A3 (en) Ligands of the avss6 integrin, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203212A3 (en) Integrin inhibitors, process for preparation thereof, their use preparation of pharmaceutical compositions and the compositions
AU2002237578A1 (en) Functional agent for decomposing nicotine and method of preparing the same
WO2002096870A3 (en) Sponge-derived terpenoids and methods of use
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
EP1245562A4 (en) ALCOHOLS 5-THIA- &#34;OMEGA&#34; - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT.
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status